[ Price : $8.95]
Federal Register notice: FDA proposes to reclassify Class 3 cytomegalovirus deoxyribonucleic acid quantitative assay devices inten...[ Price : $8.95]
Federal Register notice: FDA withdraws the approval of two Eisai NDAs for weight loss drugs Belviq tablets and Belviq XR extended-...[ Price : $8.95]
FDA accepts for review a ChemoCentryx NDA for avacopan, an orally-administered selective complement 5a receptor inhibitor for trea...[ Price : $8.95]
Two Florida men are charged as part of an Insys Subsys kickback and bribery scheme.[ Price : $8.95]
FDA dietary supplements director Steven Tave tells an industry conference about a regulatory gap between what the law requires and...[ Price : $8.95]
FDA accepts for priority review a CytRx NDA for arimoclomol for treating Niemann-Pick disease Type C.[ Price : $8.95]
A Washington Post opinion piece takes issue with President Trump and his administrations meddling for political purposes in FDA an...[ Price : $8.95]
FDA encourages stakeholders who are developing drugs containing cannabis to consider using the drug master file pathway to protect...